New digital toolkit aims to boost prostate cancer literacy across europe
NCT ID NCT07437482
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing a co-created digital health literacy tool designed to help people better understand prostate cancer prevention and care. Researchers will enroll 3,100 adults aged 40 and older, including patients, caregivers, and healthcare professionals, across six European countries. The goal is to see if the tool improves shared decision-making and knowledge about prostate cancer compared to usual care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Co-created digital health literacy intervention
- What this could lead to
- If successful, this could provide a proven strategy to help people better understand prostate cancer information and make more informed decisions with their doctors.
- What could go wrong
- This is an early-stage, observational-style trial focused on education, not a treatment. The intervention may not significantly change behavior or outcomes, and results may vary across different populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTH LITERACY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Miguel Hernández
Alicante, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new tracer light up hidden prostate cancer?
- A 45-Minute lesson could sharpen Students' minds and sleep
- Could deep breaths before surgery ward off Post-Op confusion?
- A second look: MRI screening may spot hidden prostate cancers
- Can precision protons spare the bowel in prostate cancer?
- AI coaches doctors on cancer risk talks